Aims In October 1995 in response to the results of three studies, the Committee on the
Safety of Medicines advised doctors and pharmacists that oral contraceptives containing …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

The results of three independent studies of venous thromboembolic disease (VTE) and oral
contraceptives are reviewed together with two further cohort/case-control studies which we …

Background Four studies published since December, 1995, reported that the incidence of
venous thromboembolism (VTE) was higher in women who used oral contraceptives (OCs) …

Objective: Three research articles published in late 1995 and early 1996 suggested that oral
contraceptives containing either of the newer progestogens (gestodene or desogestrel) …

Background Two recent studies, a cohort study from Denmark, and a case-control study from
The Netherlands, have reported increased risks of venous thromboembolism (VTE) among …

How did the good news about venous thromboembolism (VTE) and the combined oral
contraceptive pill (COC) become the biggest pill scare of the 1990s? What were the …

Objective To investigate the association between use of combined oral contraceptives and
risk of venous thromboembolism, taking the type of progestogen into account. Design Two …

Venous thromboembolism (VTE) is rare in young women but is associated with the use of
combined oral contraceptives (OCs). In 1995 and 1996, three studies showed a difference in …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …